A股異動丨漢宇集團跌逾9% 該股近日創新高 控股股東及其一致行動人累計減持0.59%股份
漢宇集團(300403.SZ)現跌9.33%報18.28元,暫成交20億元,最新市值110億元,年內仍累漲84%;該股上週四(2月27日)盤中高見23.86元,股價創歷史新高。漢宇集團上週五(2月28日)晚間公佈,在2025年2月25日至2025年2月27日期間,控股股東石華山先生及其一致行動人樑穎光女士、郭麗華女士通過競價交易、大宗交易等方式合計減持公司股份3,552,038股,佔公司總股本的0.59%。本次權益變動後,石華山先生及其一致行動人的持股比例由39.28%變動爲38.69%,變動觸及1%的整數倍。(格隆匯)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.